Authors




James G. Terwilliger, MPH

Latest:

Evolutions in Outpatient Cancer Care

Within the last 5 years changes to oncology private practice have led to these clinics aligning themselves with larger entities to maintain their practices.


Robert J. Sanchez, PhD, M

Latest:

Healthcare Utilization and Costs for Insured Patients With Fibromyalgia

Fibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.


Helaine Rockett, MS, RD

Latest:

Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL Control

Evaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.




Aminat Awogun, BPharm student

Latest:

How Pharmacists Can Optimize Care for Muslim Patients During Ramadan

This information will help them understand the patient medical needs during fasting and make proper adjustments in the treatment regimen where necessary.


Prasanth Puthanveetil, BPharm, PhD

Latest:

Antibiotics Administration: Factors to be Considered by Pharmacists

In recent years, health care professionals have been seeing a surge in adverse effects associated with long-term use of antibiotics, as well as abuse, not only in the United States, but around the world.


James Grana, PhD

Latest:

Factors Associated with Zostavax Abandonment

This study highlights the implications of noncompliance with the use of in-network providers for immunization services, shedding light on value-based benefits design to promote access to recommended vaccinations.


Desiree Gaines, PharmD

Latest:

Pharmacists Play Role in Impairment Care Planning

Collaborating with providers offers opportunities to help patients maintain their brain health.


Gina Dube, PharmD, CACP, RPh

Latest:

Antiplatelet Therapy for Heart Disease: A Mainstay of Prevention and Management

The number of deaths associated with cardiovascular disease in 2015 was estimated at 17.7 million and accounted for 31% of global deaths.


Elizabeth Valadez

Latest:

Restore Hope Through Pharmacy Services

Now, more than ever, is the time that nurses, pharmacists, pharmacy technicians, and physicians can help those who need access to life-saving medicines, and Dispensary of Hope is a resource.


Tina Do, PharmD, MS, BCPS

Latest:

Fostering Rapid Innovation During a Time of Crisis

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.


Lindsey Lagestee, PharmD

Latest:

Probiotics: What's the Scoop?

Data show that as many as 4 million adults take a probiotic in the United States, making probiotics some of the most widely used supplements.


Dan Steiber, RPh, Specialty Pharmacy Times® Editor-in-Chief

Latest:

Importance of Hospital Specialty Pharmacies Grows Amid Shifting Oncology Landscape

A specialty pharmacy’s specific expertise and experience in supporting patients with cancer is among its most essential attributes.


Tony Guerra, PharmD

Latest:

How Mnemonics Can Help Students Ace the PCOA

Some pharmacy schools now use Pharmacy Curriculum Outcomes Assessment scores for academic probation.


Jeffrey S. Reichard, PharmD, MS, BCPS

Latest:

A System Approach to Pharmacy Leadership

Hospital acquisitions and mergers have become common in today's health care environment.


Craig M. Doane, MA

Latest:

Patient Adherence: Identifying Barriers and Defining Solutions

Major patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.


Joseph C. Cappelleri, PhD, MPH

Latest:

Therapeutic and Subtherapeutic Dosing of Pregabalin: Medication Adherence, Healthcare Resource Utilization, and Costs

Therapeutic and subtherapeutic doses of pregabalin were compared to ascertain differences in adherence, healthcare resource use, and cost between the cohorts.


Bradi L. Frei, PharmD, MS

Latest:

Cost of Squamous Cell Cancer of the Head and Neck

The cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.


Ricky Newton, CPA

Latest:

Letter from Community Oncology Alliance

A letter to community oncology pharmacists from Ricky Newtown, CPA, director of Financial Services & Operations, Community Oncology Alliance.


Caroline Seymour

Latest:

USPSTF Updates Recommendation for Earlier Colorectal Cancer Screening

The United States Preventive Services Task Force updates recommends that colorectal cancer screening begin 5 years earlier, at age 45 instead of age 50.


funded by Eisai Inc.

Latest:

Trends in the 2012 Eisai Oncology Digest: Insurance and Cost Obstacles in Cancer Treatment

Results from Eisai Inc's online national survey of cancer patients, published in the 2012 Eisai Oncology Digest, highlight financial concerns of cancer treatment and their impact on treatment adherence.


Dan Leonard, President, National Pharmaceutical Council

Latest:

Going Beyond the Headlines on Health Spending in 4 Steps

Health care spending in the United States is at the center of a loud, fractured debate mired in deep complexity.


Anthony Bianchini

Latest:

Billions of Dollars and More Than a Decade Later, Now What?

The global launch of a new drug requires careful orchestration of sales and marketing support activities—a challenge that can have a large financial impact.


Nour Awad, BScPharm, Amjad Abuirmeileh, BScPharm, MSc, PhD

Latest:

The King Hussein Cancer Center in Jordan: Evolution of the Pharmacy Department

The pharmacy at KHCC has transformed itself into one of the leading health care providers in the Middle East.




Jonathan Greenberg, BS

Latest:

Patient Preference for Treatment Administration in Cystic Fibrosis

This study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.